The Committee will provide advice to the Director, Office of Research on Women's Health (ORWH), at the National Institutes of Health (NIH), on research activities with regards to health of women.

The Committee provides independent advice and recommendations to the Deputy Director for Intramural Research (DDIR), National Institutes of Health (NIH), and other staff within the Office of Intramural Research (OIR) on the intramural staff training programs managed by its Office of Intramural Training and Education, technology transfer programs managed by its Office of Technology Transfer, the programs managed by its other three offices, the Office of Animal Care and Use, the Office of Human Subjects Research, and the Office of NIH History, and possible future research activities in the Intramural Research Program (IRP) to be encouraged by the DDIR.

The Committee will provide advice to the Secretary of Health and Human Services (Secretary), the Assistant Secretary for Health, and the Director, National Institutes of Health (NIH), on matters related to planning, execution, conduct, support, and evaluation of biomedical research, medical science, and biomedical communications.

The Committee will provide advice to the Director, Division of AIDS (DAIDS), and the Director, National Institute of Allergy and Infectious Diseases (NIAID), in all areas of biomedical research on HIV infection and AIDS, that support progress in the detection, treatment, and prevention of HIV disease, as well as its pathogenesis, natural history and transmission.

The Committee will provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, and evaluation of the peer review of grant applications.

The Board will advise the Director, National Center for Advancing Translational Sciences (NCATS), on the conduct of the activities of the Cures Acceleration Network.

The Committee will provide advice and make recommendations to the Director, National Cancer Institute (NCI or Institute), Deputy Directors, NCI, and the Associate Director, Frederick National Laboratory for Cancer Research (FNLCR), on the optimal use of the FNLCR to rapidly meet the most urgent needs of the Institute.

The Committee will (1) monitor autism spectrum disorder research, and to the extent practicable services and support activities, across all relevant Federal departments and agencies, including coordination of Federal activities with respect to autism spectrum disorder; (2) develop a summary of advances in autism spectrum disorder research related to causes, prevention, treatment, early screening, diagnosis or ruling out a diagnosis; interventions, including school and community-based interventions, and access to services and supports for individuals with autism spectrum disorder across the lifespan of such individuals; (3) make recommendations to the Secretary of Health and Human Services (Secretary) regarding any appropriate changes to such activities, including with respect to the strategic plan; (4) make recommendations to the Secretary regarding public participation in decisions relating to autism spectrum disorder, and the process by which public feedback can be better integrated into such decisions; (5) develop a strategic plan for the conduct of, and support for, autism spectrum disorder research, including as practicable for services and supports, for individuals with an autism spectrum disorder across the lifespan of such individuals and the families of such individuals, which shall include (A) proposed budgetary requirements; and (B) recommendations to ensure that autism spectrum disorder research, and services and support activities to the extent practicable, of the Department of Health and Human Services and of other Federal departments and agencies are not unnecessarily duplicative; and (6) submit to the Congress and the President: (A) an annual update on the summary of advances described in point (2) above; and (B) an annual update to the strategic plan described in point (5) above, including any progress made in achieving the goals outlined in such strategic plan.

The Committee reviews and evaluates journals as potential titles to be indexed in the MEDLINE database by the National Library of Medicine. As defined in this charter, the Committee shall recommend to the Director, National Library of Medicine (NLM) those journals to be indexed in the MEDLINE database and to advise on matters relating to the scope and coverage of MEDLINE.

The Committee will coordinate research activities across the National Institutes of Health (NIH) and with other Federal health programs and activities on matters related to the various forms of muscular dystrophy, including Duchenne, Becker, congenital muscular dystrophy, limb-girdle muscular dystrophy, myotonic, facioscapulohumeral muscular dystrophy and other forms of muscular dystrophy.

The Board will review and assess Federal research priorities, activities, and findings regarding medical rehabilitation research, and shall advise the Director, National Center for Medical Rehabilitation Research (NCMRR) and the Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on the provisions of the Research Plan. The Board will advise the Director, National Institutes of Health (NIH), the Director, NICHD, and the Director, NCMRR, on matters and policies relating to NCMRR’s medical rehabilitation research and training programs.

The NAEPP was created to address asthma issues in the United States; to raise awareness of patients, health professionals, and the public that asthma is a serious chronic disease; and to ensure the recognition of the symptoms of asthma by patients, families, and the public and the appropriate diagnosis by health professionals. The ultimate goal of the NAEPP is to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality. The Committee’s primary mission is to provide advice to the Director, National Institute of Health (NIH), and the National Heart, Lung, and Blood Institute (NHLBI) on matters concerning asthma and to facilitate the efficient and effective exchange of information on asthma activities among Federal programs and the committee’s member agencies and voluntary health organizations. To accomplish these broad program goals, the Committee is made up of members from NHLBI, as well as representatives from other Federal agencies, intermediaries including major medical associations, voluntary health organizations, and community programs.

The Board will provide advice to the Director and Deputy Director, National Cancer Institute (NCI or Institute), and the Director of each NCI Division, Office, Center (DOC) on a wide variety of matters concerning scientific program policy, and progress and future direction of extramural research programs.

The Committee will provide advice to the Director, National Cancer Institute (NCI), NCI Deputy Directors, and the Director of each NCI Division, on matters related to the conduct, oversight, and implementation of clinical trials and translational research across the NCI.

The Committee will provide advice to the Director, National Cancer Institute (NCI or Institute), with respect to promoting research outcomes that are in the best interest of cancer patients. To this end, the Committee will conduct these activities with the intent to identify new approaches, promote innovation, recognize unforeseen risks or barriers, and identify unintended consequences that could result from NCI decisions or actions. Additionally, the Committee will provide insight into enhancing input, optimizing outreach, and promoting strong collaborations, all with respect to non-scientist stakeholders.

The purpose of the NSABB is to provide, as requested, advice, guidance, and recommendations regarding biosecurity oversight of dual use research, defined as biological research with legitimate scientific purpose that may be misused to pose a biologic threat to public health and/or national security. The NSABB will provide advice on and recommend specific strategies for the efficient and effective oversight of federally conducted or supported dual use biological research, taking into consideration both national security concerns and the needs of the research community to foster continued rapid progress in public health and agricultural research. Toward this end, the NSABB will also provide strategies to raise awareness of dual use issues relevant to the life science and related interdisciplinary research communities. In addition, pursuant to Section 205 of the PAHPA, when requested by the Secretary of Health and Human Services (HHS), the NSABB shall also provide to relevant Federal departments and agencies, advice, guidance, or recommendations concerning (1) a core curriculum and training requirements for workers in maximum containment and biological laboratories; and (2) periodic evaluation of maximum containment biological laboratory capacity nationwide and assessments of the future need for increased laboratory capacity.

The purpose of the Board is to advise, consult with, and make recommendations to the NIH Director (or designee) and the NIH Clinical Center Chief Executive Officer (CEO) with respect to maintaining excellence in hospital operations, safety and quality, unique clinical research care requirements for Clinical Center patients, regulatory compliance, clinical research, and hospital leadership performance oversight. The Board’s advice and recommendations may regard issues, processes, studies, and/or reports on a range of topics in relation to the NIH Clinical Center and CEO’s duties and authorities.

The Committee will provide advice to the Director, National Institutes of Health (NIH), on matters related to the conduct and oversight of research involving emerging technologies in biomedical science (also referred to as emerging biotechnologies).

The Council will provide advice to the Director, Office of AIDS Research (OAR) on the planning, coordination, and evaluation of research and other activities in respect to acquired immune deficiency syndrome (AIDS) conducted or supported by the agencies of the National Institutes of Health (NIH).

The Panel will provide advice directly to the President on matters relating to the development and execution of the activities of the National Cancer Program.

The Committee will provide advice to the Director, National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP), the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), and the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) regarding ICCVAM activities. SACATM also advises the NIEHS and NICEATM on NICEATM activities relating to ICCVAM. The purposes of the ICCVAM as defined in the law are to increase the efficiency and effectiveness of Federal agency test method review; eliminate unnecessary duplicative efforts and share experiences between Federal regulatory agencies; optimize utilization of scientific expertise outside the Federal government; ensure that new and revised test methods are validated to meet the needs of Federal agencies; and reduce, refine, or replace the use of animals in testing, where feasible. NICEATM supports activities and collaborates with ICCVAM to facilitate the development, scientific review, validation, and interagency consideration of novel toxicological methods of multiagency interest that predict human health risks while reducing, refining, and/or replacing animal tests. NICEATM promotes participation and communication with stakeholders throughout the process of test method development and validation.

The purpose of the Board is to advise, consult with, and make recommendations to the Secretary of Health and Human Services (Secretary), the Director, National Institutes of Health (NIH), and other appropriate agency officials on the use of the organizational authorities set forth in 42 U.S.C. 281(d)(2)-(4), section 401(d)(2)-(4) of the PHS Act, as amended, which include: (1) establishing, reorganizing, or abolishing national research institutes; (2) reorganizing the offices within the Office of the Director, NIH, including adding, removing, or transferring the functions of such offices or establishing or terminating such offices; and (3) reorganizing divisions, centers, or other administrative units within an NIH national research institute or national center, including adding, removing, or transferring the functions of such units, or establishing or terminating such units.

The Committee will provide advice to the Director, National Institutes of Health (NIH), the Director, National Heart, Lung, and Blood Institute (NHLBI), and the Director, Division of Blood Diseases and Resources (DBDR), on matters related to planning, execution, conduct, support, and evaluation of research in sickle cell disease.

The Board will provide advice to the Director, National Institutes of Health (NIH), through the Director, National Heart, Lung, and Blood Institute (NHLBI), and the Director, National Center on Sleep Disorders Research (NCSDR), on matters related to planning, execution, conduct, support, and evaluation of research in sleep disorders.

The purpose of the Board is to advise, consult with, and make recommendations to the Director, National Institutes of Health (NIH); the Deputy Director for Intramural Research, NIH; the Director, National Library of Medicine (NLM); and the Scientific Director, NLM, with respect to the intramural research program of the NLM, including research and research training conducted within the National Center for Biotechnology Information (NCBI) and the Lister Hill National Center for Biomedical Communications (LHNCBC).

The National Heart, Lung, and Blood Institute (NHLBI) Intramural Research Program conducts and supports basic and clinical research with respect to heart, blood vessels, lungs, blood cells and bone marrow. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors

The National Institutes of Health (NIH) Clinical Center's Intramural Research Program provides research support to the institutes and centers of Intramural Program of the NIH and conducts and supports basic and clinical research in numerous specialties of medicine. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientists, expert scientists from outside the NIH are invited to join the Board of Scientific Counselors.

The National Institute of Environmental Health Sciences (NIEHS) Division of Translational Toxicology’s (DTT) Intramural Research Program conducts biomedical health-related research and provides advice to the Institute in carrying out its programs with respect to mechanistic and applied toxicological research. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic and clinical child health and human growth and development research. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientists, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Cancer Institute (NCI) Intramural Research Program conducts biomedical health-related research in its own laboratories. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientists, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors, NCI (Board). The Board provides advice to the Institute in carrying out its intramural programs in the areas of basic, clinical, and epidemiological research and provides advice to the Institute regarding a wide variety of matters concerning scientific program policy and progress and itiatives within the NCI Intramural Research Program.

The National Center for Complementary and Integrative Health (NCCIH) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Center in carrying out its programs with respect to basic and applied research, training researchers in complementary and integrative health practices, and disseminating health information with respect to identifying, investigating and validating complementary and integrative treatments, diagnostic and prevention modalities, disciplines and systems. NCCIH's Division of Intramural Research focuses on basic, clinical, and translational research focusing on the role of the brain in perceiving, modifying, and managing pain. Research projects include investigating the role of the brain in pain processing and control, and how factors such as emotion, attention, environment, and genetics affect pain perception. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientists, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors, NCClH.

The National Eye Institute (NEI) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to the conduct of research, training, the dissemination of health information, and other programs with respect to vision research. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Human Genome Research Institute (NHGRI) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out is programs with respect to genetics and genomics research. In order to secure unbiased and objective evaluation of intramural programs and of the work of the individual scientists, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research Program conducts and supports research and training relating to arthritis and musculoskeletal and skin diseases. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to biomedical imaging, biomedical engineering, and associated technologies and modalities with biomedical applications. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Dental and Craniofacial Research (NIDCR) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to the prevention, diagnosis, and treatment of dental diseases and conditions and craniofacial research.  In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic and clinical medical sciences. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Environmental Health Sciences (NIEHS) Intramural Research Program conducts biomedical health-related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to environmental health sciences, and associated technologies and modalities with environmental health applications. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Mental Health (NIMH) Intramural Research Program conducts and supports research relating to the causes, diagnosis, treatment, control, and prevention of mental disorders and conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic and clinical mental health research. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute of Neurological Disorders and Stroke (NINDS) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic, translational, and clinical research in neuroscience, neurology, neurosurgery. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute on Aging (NIA) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to the aging process and the diseases and other special problems and needs of the aged. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic and clinical research on alcohol abuse and alcoholism. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program conducts basic and clinical research in human communication, with a primary interest in hearing and balance. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute on Drug Abuse (NIDA), Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to basic, preclinical and clinical research on mechanisms that underlie substance use disorders, addiction and relapse.  In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The National Institute on Minority Health and Health Disparities (NIMHD) Intramural Research Program conducts social and behavioral health sciences; population and community health sciences; and epidemiology and genetics research in its own offices and laboratories and provides advice to the Institute in carrying out its programs with respect to minority health, health disparities and health equity research. The National Institute of Nursing Research (NINR) Division of Intramural Research conducts research that applies a holistic, contextualized perspective to understand and address factors that will optimize health and advance health equity in its own offices and laboratories and provides advice to the Institute in carrying out its programs with respect to nursing research to solve pressing health challenges and inform practice and policy. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors. This Board of Scientific Counselors will serve both the NIMHD and NINR intramural research programs.

The National Institute of Allergy and Infectious Diseases (NIAID) Intramural Research Program conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to allergy, immunology, and infectious diseases. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The Board will provide advice to the National Toxicology Program (NTP, also referred to as "Program") Executive Committee and Program Director on matters of scientific program content, to evaluate the scientific merits of the intramural and collaborative programs of the NTP, and to provide external scientific advice on NTP activities.

The Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) conducts biomedical health related research in its own laboratories and provides advice to the Institute in carrying out its programs with respect to research that facilitates the development of effective vaccines for human disease. In order to secure unbiased and objective evaluation of intramural research programs and of the work of the individual scientist, expert scientists from outside the National Institutes of Health (NIH) are invited to join the Board of Scientific Counselors.

The IRG reviews funding applications and proposals, including but not limited to, grant and cooperative agreement applications and contract proposals for research projects, and for research and training activities in areas relevant to aging and neurodegeneration.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to immunological, biological, and chemical strategies for infectious disease intervention, control, and prevention. Included are the discovery and development of anti-infective agents and vaccines for the prevention and treatment of infectious diseases, antimicrobial resistance, and control strategies which cover all investigative aspects of vectors associated with disease transmission.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to translational and clinical investigations that encompass cancer therapeutic development and cancer treatment. This includes the mechanism of action of cancer therapeutic agents in both in vitro and in vivo model systems; identification and validation of new druggable targets; development and evaluation of experimental therapies of neoplastic diseases; development or optimization of treatment modalities; and radiation biology and therapy.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to (1) the broad areas of biobehavioral processes; including conditioning, affect and stress, regulatory and hormonal function, and appetitive behaviors; (2) the broad areas of language and communication, learning, cognition and perception, and motor function, including sound production; and (3) the broad areas of behavioral, developmental, and substance use disorders including psychopathology in infants, children, adolescents and adults.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to gene and drug delivery systems, imaging principles for molecules and cells, modeling of biological systems, bioinformatics, statistics and data management, instrumentation, chips and microarrays, biosensors, and biomaterials.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to synthetic and biological chemistry, bioinorganic and bioorganic/chemical biology, drug design/medicinal chemistry, bioconjugate chemistry, biomaterials, biomimetic chemistry, imaging agents, metals in chemistry, molecular recognition, molecular design, macromolecular structure-function relationships, protein, nucleic acid, and carbohydrates, protein-ligand interaction, membrane architecture, membrane protein folding, assembly, and dynamics, membrane-based energy transduction, lipid metabolism and function, lipid-protein interactions, biophysics of membrane fusion mechanisms, bioanalytical techniques, biophysical techniques, software development applied to bioanalytical instrumentation, instrumentation control, data reduction, data analysis, or data mining.

The IRG reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biology of human development and aging.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to basic, applied, and clinical proposals to investigate the cornea, lens, conjunctiva, ciliary body and lachrymal gland, anatomical, cellular and functional basis of neural disease and injury across the life span, genetic, molecular and cellular basis of acute brain injury across the life span, anatomical, the area of neural disease and injury across the life span that focus on neurotransmitter or neurotrophic function including associated receptors, in vivo studies of the genetic, molecular, and cellular basis of chronic neural disorders across the life span, central and peripheral nervous system disorders, including neuromuscular disorders, and injury across the life span where the focus is on infections, immune, inflammatory or vascular mechanisms, developing brain and spinal cord, neurobiological basis of addictive, behavioral, cognitive and emotional disorders across the life span, and the pathophysiology of a broad range of psychiatric, addictive and neurological disorders and biological systems that mediate cognitive, behavioral, emotional, social and learning abnormalities.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to development, physiology, and pathophysiology of the heart and circulatory systems, themes of development, muscle contraction including cardiac hypertrophy and failure, cardiovascular electrophysiology and arrhythmias, and myocardial ischemia and infarction, as well as basic and clinical aspects of lung cellular, molecular, and immunobiology, lung injury, repair and remodeling, and respiratory integrative biology in normal and disease states.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to cell growth, proliferation and cell cycle control; nuclear architecture and transport; RNA trafficking and localization; posttranslational modifications; protein processing, glycosylation and folding; membrane structure and function; lipid traffic and metabolism; cell asymmetry and polarity; ion transport and dynamics and protein translocation; the secretary pathway, endocytosis, exocytosis and phagocytosis; degradative processes; cell adhesion, junctions and cell fusion; extracellular matrix and ECM receptors; signaling mechanisms and networks; integrative cell physiology including circadian clocks, stress and oxidative damage response; motors, filaments and cargoes; cell locomotion; mitosis and meiosis; cell death; multicellular interactions and development including higher order complexity in tissues; cell differentiation and oncogenic transformation; and the development of new methodologies, including advances in imaging and biosensors.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to basic and clinical aspects of gastrointestinal, hepatobiliary and pancreatic physiology and pathobiology, and on the disposition and action of nutrients and xenobiotics.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to crosscutting technologies that serve all of the neurosciences, including neuroinformatic and imaging and molecular neurogenetics; crosscutting emerging science in small business area for all of the neurosciences; and the training areas for all of the neurosciences.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to endocrinology and reproductive biology, as well as research relating to basic and clinical aspects of metabolism, nutrition and gastroenterology, including but not limited to, metabolic studies in normal and disease states at the organism, tissue or cellular level, the requirements of living organisms for nutrients, vitamins and trace elements and nutritional practices.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to genomic studies, computational biology and technology development, including development of new genetic tools and resources, global analysis of genetic systems, biological and computational resource development, and classification, storage, access, analysis and integration of genetic and other biological information, genetic variation and evolution, the description, analysis and modeling of induced and natural genome variation, and comparisons between species, all aspects of quantitative genetics, including complex trait mapping in humans and a wide variety of other species, the involvement of genetics in human health and disease, including the discovery, application and interpretation of gene and genomic variation influencing phenotype and the development of experimental and computational approaches to the identification of disease-related genes.

The IRG reviews funding applications and proposals, including, but not limited, to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biostatistical methods and research design, health services organization and delivery, nursing science, biomedical computing and health informatics, community prevention, nursing, and health informatics initiatives.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to infectious diseases and immunology, covering virology and viral pathogenesis (including HIV), bacteriology and bacterial pathogenesis, fungal pathogenesis, parasitology and parasitic diseases, cellular and molecular immunology, and fundamental aspects of the innate and adaptive immune system.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to infectious diseases and immunology, addressing the immune system’s role in host interactions with infectious agents and the mechanisms and treatment of diseases when the immune system has a major role, including autoimmunity, immune-mediated diseases, and immune tolerance. Also included are basic science, pre-clinical, and clinical studies of the pathogenesis of HIV/AIDS associated pathogens and cancers, co-infection with other infectious disease, and co-morbidities associated with chronic infections of HIV.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to (1) neural basis of emotional and motivational behavior; (2) regulation of function, at the systems level, by neuroendocrine and neuroimmune influences; (3) the analysis of neural system function under various behavioral states, e.g., sleep and hibernation; (4) the maintenance of homeostasis by the autonomic nervous system; (5) chemosensation, hearing, balance, touch and somatosensation; (6) motor-system and sensory motor integration; (7) the integration of multisensory information; (8) the development and alteration of memory and other cognitive processes that accompany aging; (9) computational and theoretical models of cognitive processes; (10) mechanisms that underlie neural coding of complex stimuli; (11) attention and its effect on information processing in the nervous system; (12) those portions of the eye, brain, and intraocular muscle system that serve visual sensation; and (13) neuropharmacological effects of alcohol and toxicants. 

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biological chemistry, biophysics and cell biology, drug discovery and development, devices and detection systems, biomaterials, delivery systems and nanotechnology, computational biology, imaging and data mining, genes, genomes and genetics, environmental monitoring, and basic translational oncology.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biophysics of neural systems, cellular and molecular biology of glia, cellular and molecular biology of neurodegeneration, molecular neuropharmacology, neurodifferentiation, plasticity, and regeneration, neurogenesis and cell fate neural oxidative metabolism and death, neurotransporters, receptors, and calcium signaling, and synapses, cytoskeleton and trafficking.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to arthritis, connective tissue, skin, musculoskeletal rehabilitation sciences, musculoskeletal tissue engineering, oral, dental and craniofacial sciences, skeletal biology development and disease, skeletal biology structure and regeneration, skeletal muscle biology and exercise physiology.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to cancer etiology, cancer genetics, cancer molecular pathobiology, molecular oncogenesis tumor cell biology, tumor microenvironment and tumor progression and metastasis.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to translational and clinical investigations including clinical trials that encompass cancer prevention, diagnosis and treatment. Included are immune therapies for cancer; the translation of cancer research to clinical practice; chemoprevention; and the development of biomarkers/signatures for tumor detection and diagnosis.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to epidemiologic or demographic research relating to the change, composition and structure for human populations and various dimensions of health.

The IRG reviews funding applications and proposals, including, but not limited to, grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biological, psychological, cultural, and social conditions and traits that affect the manifestation, prevention, treatment or management of physical and mental diseases and disorders.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to social, interpersonal, community, and cultural influences on health, development, and well-being across the life span.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biomedical imaging technology, bioengineering, technology and surgical sciences, clinical molecular imaging and probe development, medical imaging and surgery, anesthesiology and trauma.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to basic and clinical aspects of vascular and hematological components of the circulatory system in normal and disease states including, but not limited to, vascular hemodynamics and hypertension, neural and integrative systems, inflammation, atherosclerosis and vascular cell and molecular biology with an additional focus on hematopoiesis, blood cells, including red cells, granulocytes, monocytes, leukocytes and mechanisms of hemostasis and thrombosis.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to allergic and immunologic diseases as well as in the areas of immunobiology, immunogenetics, immunopathology, immunochemistry, and transplantation biology. It also gives advice on policy, planning and program development as well as evaluates programs of institute emphasis in these areas.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects, and for research and training activities in areas relevant to arthritis and musculoskeletal and skin diseases, including sports-related disorders.
 

The BILDS Review Committee reviews grant and cooperative agreement applications for research and resource projects and for research training activities that develop novel methods and approaches in informatics, library and data sciences for use in health care, public health and basic biomedical research.

 The IRG provides advice and recommendations on the scientific and technical merit of applications concerning investigators wishing to gain access to the genotyping and genetic analysis capabilities of the Center for Inherited Disease Research (CIDR) in scientific areas relevant to the identification of the genetic loci and allelic variants that play important roles in abnormal development, physiology, and behavior. The members will survey as scientific leaders, the status of research and research training in their fields.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to disorders affecting hearing, balance, voice, speech, language, taste, and smell.
 

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to factors in the environment that  affect human health, directly or indirectly.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to maternal and child health, reproductive and population sciences, intellectual and developmental disabilities, and medical rehabilitation.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to heart, blood vessel, lung, and blood diseases, sleep disorders, and blood resource management.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to microbiology, including basic   microbiology, molecular biology, microbial chemistry, parasitology, virology, bacteriology, antimicrobial chemotherapy, infectious diseases, and AIDS, including prevention and treatment of the major opportunistic infections associated with AIDS.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to cancer cause, diagnosis, treatment, and prevention; and contract proposals relating to all facets of cancer.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to the Human Genome Project.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to the cause, diagnosis, and treatment of dental and craniofacial conditions and diseases that include both basic and clinical research.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to diabetes mellitus, endocrine and metabolic diseases; digestive diseases and nutritional disorders; and kidney, urologic, and hematologic diseases.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to basic biomedical, clinical, and  behavioral sciences.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects, and for research and training activities in areas relevant to mental health and mental disorders.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to neurological basic science and clinical disorders and stroke.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to biomedical and behavior sciences, economics, law, ethics and administration important to the National Institute of Nursing Research.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to clinical, basic, behavioral, and social sciences related to aging.

The IRG reviews grant and cooperative agreement applications and contract proposals for research projects, and for research and training activities in areas relevant to alcohol abuse and alcoholism in the areas of biomedical, basic and clinical neuroscience, basic behavioral science, treatment, health services, epidemiology, prevention, human development, and AIDS.

The IRG reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to drug abuse and addiction including, basic and clinical neuroscience, basic behavioral science, medications development, treatment, health services, epidemiology, prevention, human development, and AIDS.

The IRG reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to training and career development programs and activities in the areas of neurological disorders and stroke.

The Board will provide advice to the Director, National Institutes of Health (NIH), and the Council of Councils (Council) established under section 402(l) of the PHS Act, in carrying out section 404I of the PHS Act (“Biomedical and Behavioral Research Facilities”). 

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to neuroscience, development and aging, behavioral and population sciences, basic and integrative biological sciences, physiological and pathological sciences, and translational and clinical sciences.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to maternal and child health, reproductive and population sciences, intellectual and development disabilities, and medical rehabilitation.

The SEP reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in the broad areas relevant to basic and clinical cancer research. The Panel evaluates proposals for support to make available to the research community, on a competitive basis, contract resources for the preclinical development of drugs, biologics, clinical assays, and other developmental programs that would ultimately benefit the advancement of clinical studies. The Panel will provide input to NCI on scientific prioritization of National Clinical Trials Network (NCTN) concepts across diseases.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to research infrastructure activities across broad areas of biomedical and behavioral research, including clinical and translational research; comparative medicine, which includes animal models and related research resources, support of primate centers, and laboratory animal medicine and research; development of specialized or exploratory centers; biotechnology research and development related to biophysics, biomedical engineering, molecular and cellular biological structure and function; minor alteration and renovation of biomedical research facilities; and investigator-initiated research projects.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to complementary and integrative health research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to vision research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to broad areas of cardiovascular, pulmonary, and blood diseases and blood resources research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to the Human Genome Project.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to allergic and immunologic diseases and disorders, transplantation, vaccinology, microbiology and infectious diseases, including tropical diseases, AIDS and AIDS-related research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to arthritis and musculoskeletal and skin diseases, including sports-related disorders.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to biomedical imaging and bioengineering, enabled by relevant areas of information science, physics, chemistry, mathematics, material science, engineering, and computer sciences.

The SEP provides advice and recommendations on funding applications and proposals, including, but not limited to, grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in the broad areas relevant to the cause, diagnosis, and treatment of dental and craniofacial conditions and diseases that include both basic and clinical research. 

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to diabetes, endocrine and metabolic diseases; digestive diseases and nutritional disorders; and kidney, urologic, and hematologic diseases.

The SEP provides advice and recommendations on funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to the effects of the environment on human health, directly or indirectly.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to biomedical research and the behavioral sciences.

The SEP provides advice and recommendations on funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to mental health and mental disorders.

The SEP provides advice and recommendations on funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to neurological basic science and clinical disorders and stroke.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to nursing research, such as acute and chronic illness, prevention, community health and other related areas of research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to clinical, basic, behavioral, and social sciences related to aging.

The SEP reviews funding applications and proposals, including, but not limited to, grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to the effects of alcohol in the areas of biomedical, basic and clinical neuroscience; basic behavioral science; treatment; health services; epidemiology; prevention; human development; and HIV/AIDS.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to communication sciences and disorders, such as hearing, balance, smell, taste, voice, speech, and language.

The SEP reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in areas relevant to drug abuse and addiction including, basic and clinical neuroscience, basic behavioral science, medications development, treatment, health services, epidemiology, prevention, human development, and AIDS.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to minority health and health disparity research.

The SEP reviews funding applications and proposals, including but not limited to grant and cooperative agreement applications and contract proposals, for research projects and for research and training activities in areas relevant to informatics, library and data sciences for use in health care, public health and basic biomedical research.

The Panel will advise the National Toxicology Program (NTP, also referred to as “Program”) and its specialized centers on agents of public health concern, new/revised toxicological test methods, or other issues.

The SEP provides peer review of the scientific and technical merit of grant and cooperative agreement applications and contract proposals for research projects, including science education projects; research and training activities, and research infrastructure activities across broad areas of biomedical and behavioral research, including comparative medicine, which includes animal models and related research resources, support of primate centers, and laboratory animal medicine and research; and biospecimen repositories and databases; and conference grants and cooperative agreements.